<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Microbiology &amp; Immunology</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F2DE429D-50EB-42C0-B577-345E9708312A"><gtr:id>F2DE429D-50EB-42C0-B577-345E9708312A</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Andrew</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4AFB4C11-74C1-4022-BA11-14A748667550"><gtr:id>4AFB4C11-74C1-4022-BA11-14A748667550</gtr:id><gtr:firstName>Kumar</gtr:firstName><gtr:surname>Rajakumar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A0AFA01E-00C0-4C35-8FC9-2DB108656028"><gtr:id>A0AFA01E-00C0-4C35-8FC9-2DB108656028</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Barer</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300403"><gtr:id>37ABCA75-EF6B-4105-A0FF-E44B5BC594BE</gtr:id><gtr:title>The genetic basis for the distinctive properties of M. tuberculosis CH; a highly virulent strain from a school outbreak.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300403</gtr:grantReference><gtr:abstractText>Tuberculosis, a chronic and predominantly respiratory disease caused by the bacterium Mycobacterium tuberculosis (MTB), remains one of the major causes of disease and death in humanity. There are currently over eight million new cases of tuberculosis worldwide every year and, in some UK cities rates of the disease are climbing. Evidently we do not understand MTB well enough to bring it under control it through drug treatment or vaccination. 

A very large outbreak of tuberculosis was detected in a Leicester school in 2001. The size and nature of the outbreak made it a powerful ?natural experiment? that presented a rare opportunity to progress our understanding of tuberculosis. We have found that the strain of MTB responsible for the outbreak, which we have designated CH, has exceptional properties. It is highly aggressive in animal infections, is most unusual in the way it interacts with the immune system and is strikingly altered in the way it metabolises lipids. In this project we aim to find and understand the genes responsible for these properties.

Because the complete genetic complement of a standard MTB strain has already had its genetic code sequenced, we have been able to compare the DNA of CH to this sequence. Our preliminary studies have identified ten genes that may be connected to CH?s unusual properties. We propose to extend these studies to look for other genes that may be important. The core of the project will be to investigate the importance of specific genes to each the exceptional properties of CH that we have detected.

The properties of CH provide clues to why MTB has been so difficult to control. Through understanding the genetic basis of these properties we aim to enable the development of new ways of treating and preventing tuberculosis.</gtr:abstractText><gtr:technicalSummary>In 2000-2001, Mycobacterium tuberculosis strain CH caused an abnormally large outbreak of more than 300 infections linked to a single index student in a Leicester school; 23% of these have progressed to overt disease requiring treatment. The outbreak raised the possibility that CH has exceptional properties whose elucidation will provide important insights into tuberculosis, an infection that affects one third of humanity. 

By genomic microarray analysis we have identified six large-scale polymorphisms (LSPs) in CH compared to the sequenced strain, H37Rv. Subsequent PCR analysis of the LSP loci in 60 recent local isolates representing all major circulating RFLP types, has shown that only outbreak-related isolates harbour all six LSPs and that several other genetically-related and -distinct recent isolates bear three or four of these LSPs in different combinations. These polymorphisms in CH and related strains provide a series of ?natural mutants? that constitute an outstanding initial resource for the work we propose.

Further preliminary studies have led us to conclude that CH has exceptional properties; notably, when compared to H37Rv, it kills immunodeficient (SCID) mice almost twice as rapidly, its lipid profile differs in at least two prominent features and it provokes almost no IL-12p40 in human monocytes. Thus, in three areas of central interest to tuberculosis research, virulence, lipid metabolism and innate immunity, CH exhibits emphatically clear phenotypes that demand further investigation. 

Using wild type and knock-in/knock-out recombinant strains we will test the hypothesis that the differences in phenotype between CH and H37Rv are attributable to polymorphisms at specific loci in CH. The loci to be analysed will be selected from the identified LSPs and from further array-based studies that will detect ?extra? genes in CH and small-scale polymorphisms that affect its transcriptome, as compared to H37Rv. Depending on the results of a screening algorithm, wild type and recombinant strains bearing polymorphisms will be selected or constructed and analysed in detail for their phenotypic traits. 
The overall objective is to determine the relationships of specific M. tuberculosis genetic polymorphisms to in vitro growth rate; production of two specific lipid components (triacylglycerols and a glycolipid to be characterized within the project); mean survival time in SCID mice (supplemented with immunocompetent mouse infection studies on key strains); and to IL-12p40 production in human monocytes. The resultant advances in our understanding of the genetic basis for any one of these phenotypes could be of profound value to the fight against tuberculosis.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>261137</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Centre for Clinical Tropical Medicine</gtr:department><gtr:description>Studies on the Leicester TB outbreak strain</gtr:description><gtr:id>473945F4-1D13-47E9-A50D-0A41CBCCB0D1</gtr:id><gtr:impact>The work was published in PNAS (17028173) and received significant press attention at the time (see dissemination to non-academic audiences</gtr:impact><gtr:outcomeId>44AB6FBA0E9-1</gtr:outcomeId><gtr:partnerContribution>Prof Wilkinson and colleagues introduced &amp;quot;Knock-in&amp;quot; constructs that we had made into M. tuberculosis strain CH. These individually complemented ten gene deletions that we had identified in Liecester. Prof Wilkinson's team then demonstrated that complementation of the deletion affecting the deleted gene Rv1519 reversed the ability of CH to induce higher amounts of IL-10 than two well characterized strains of M. tuberculosis.</gtr:partnerContribution><gtr:piContribution>We characterized the outbreak strain by microarray analysis designed the strategies to make the knock-in constructs then made the majority of these. We recognized the significance of the Rv1519 polymorphism as identical to that identified in global study of M. tuberculosis polymorphisms and that this deletion defines a lineage that is strongly associated with patients with an ethnic origin in the Indian subcontinent (the major population affected by tuberculosis in Leicester). Since complementing the Rv1519 deletion corrected the immunosuppressive feature identified above we were able to report the first assignment of a phenotype to a lineage defining polymorphism. While this discovery did not explain the epidemic potential of strain CH it did open the gate to further investigations of pathogen/host co-evolution in tuberculosis.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press interviews and press release</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>9D19B3CE-61BE-4044-B09B-13081421D979</gtr:id><gtr:impact>Both Prof Wilkinson and I were interviewed by the broadsheet press and short repots appeared in daily newspapers (Telegraph and Independent)

Recognition of the public relevance of our studies on tuberculosis and an appreciation of the subtle interplay between host and pathogen in infection.</gtr:impact><gtr:outcomeId>EF518A1499E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>578141</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2019-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9DA269A6-FED3-462D-B473-C94CCF3181A9</gtr:id><gtr:outcomeId>58bd740c7b0877.71474168</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant/Henry Smith Charity</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>The Henry Smith Charity</gtr:fundingOrg><gtr:id>C71963A4-DEA2-4C9E-B982-70878DD95A92</gtr:id><gtr:outcomeId>78749DD5B140</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6F42A698-F66F-496B-A1C3-538C469D17F8</gtr:id><gtr:title>Translational genomics to develop a Salmonella enterica serovar Paratyphi A multiplex polymerase chain reaction assay.</gtr:title><gtr:parentPublicationTitle>The Journal of molecular diagnostics : JMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c67389baacab403b1120a097d940253a"><gtr:id>c67389baacab403b1120a097d940253a</gtr:id><gtr:otherNames>Ou HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1525-1578</gtr:issn><gtr:outcomeId>pm_16537_17_17975028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE4FE7D2-453B-45AC-AB95-4894EA3A3361</gtr:id><gtr:title>A two-tube combined TaqMan/SYBR Green assay to identify mycobacteria and detect single global lineage-defining polymorphisms in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of molecular diagnostics : JMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7583ed0b6c8ef933175e894ee4b2483e"><gtr:id>7583ed0b6c8ef933175e894ee4b2483e</gtr:id><gtr:otherNames>Cheah ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1525-1578</gtr:issn><gtr:outcomeId>pm_16537_27_20093392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA1BE7EA-F236-419C-AAFA-25A32701EA81</gtr:id><gtr:title>A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9500298a60b263243bbade25ef5d3789"><gtr:id>9500298a60b263243bbade25ef5d3789</gtr:id><gtr:otherNames>Newton SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>967EB39593A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E1BC540-317D-452D-A798-D83933C460E9</gtr:id><gtr:title>Evaluation of molecular-Beacon, TaqMan, and fluorescence resonance energy transfer probes for detection of antibiotic resistance-conferring single nucleotide polymorphisms in mixed Mycobacterium tuberculosis DNA extracts.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52392b1eb66e6e6a326669df2d442861"><gtr:id>52392b1eb66e6e6a326669df2d442861</gtr:id><gtr:otherNames>Yesilkaya H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>pm_16537_17_17021120</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D3B06A6-A6FE-4922-9C2E-ABEB29C4741C</gtr:id><gtr:title>The genetic portrait of an outbreak strain.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52392b1eb66e6e6a326669df2d442861"><gtr:id>52392b1eb66e6e6a326669df2d442861</gtr:id><gtr:otherNames>Yesilkaya H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>0F8C9D58F63</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E95272F6-F5ED-4616-B83D-8573E6F24B1D</gtr:id><gtr:title>Face mask sampling for the detection of Mycobacterium tuberculosis in expelled aerosols.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c06d92173eb1564a7391e886577f4cf"><gtr:id>4c06d92173eb1564a7391e886577f4cf</gtr:id><gtr:otherNames>Williams CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545be0c1b01b75.84720391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>435A7EC9-5F2F-4570-8818-7B1859150C10</gtr:id><gtr:title>Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7d8df257e748e69522231f52f1a1bc7"><gtr:id>a7d8df257e748e69522231f52f1a1bc7</gtr:id><gtr:otherNames>Sloan DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5675e0ef48fcf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F99CD92-8E07-4F7E-B590-63ADBA71CF70</gtr:id><gtr:title>Tb Airborne Transmission: First Gene Expression Signatures Of Captured, Uncultured M. Tuberculosis From Human Source Aerosol</gtr:title><gtr:parentPublicationTitle>AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2d06eda41aba96b9eda90119962f2ed"><gtr:id>f2d06eda41aba96b9eda90119962f2ed</gtr:id><gtr:otherNames>Nardell E. A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>58bd666d814f62.40330435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F76FEDE4-45D5-4139-987E-5BEFCDCDC95D</gtr:id><gtr:title>Superior T cell activation by ESAT-6 as compared with the ESAT-6-CFP-10 complex.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02da14090fea464a16376233d66ef7a3"><gtr:id>02da14090fea464a16376233d66ef7a3</gtr:id><gtr:otherNames>Marei A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>pm_16537_17_16186161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>249E8C33-4D2E-4B64-ACCA-7E8159052963</gtr:id><gtr:title>Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06401c36f9e4ae82ffdaec657dbb419a"><gtr:id>06401c36f9e4ae82ffdaec657dbb419a</gtr:id><gtr:otherNames>Pardini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>pm_16537_17_19539531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61131D16-31D4-48F8-B32A-8C4A09667DAD</gtr:id><gtr:title>Use of genome level-informed PCR as a new investigational approach for analysis of outbreak-associated Mycobacterium tuberculosis isolates.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adc6888036114c4c99aa8ec1d5e26311"><gtr:id>adc6888036114c4c99aa8ec1d5e26311</gtr:id><gtr:otherNames>Rajakumar K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>pm_16537_17_15131145</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300403</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>